http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2237571-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85067b2fb5eade08a0302ffac7cd2571 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-64 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 |
| filingDate | 1996-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_962749ace8103445a3023e02648c0aab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5dc0d796e5cd798c207906d06b9bcda |
| publicationDate | 2007-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2237571-C |
| titleOfInvention | A glibenclamide-metformin combination for the treatment of diabetes mellitus of type ii |
| abstract | A combination of glibenclamide and metformin such that, when administered in the form of pharmaceutical composition in the treatment of diabetes mellitus of type II, the ratio between the two active principles allows to obtain an optimum therapeutical effect at any time of the progression of the disease, avoiding to make use of the insulin therapy in the most severe cases. |
| priorityDate | 1995-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 113.